Early Reversal of Defunctioning Stoma Trial
ELSOR
1 other identifier
observational
20
1 country
1
Brief Summary
In this trial will be investigated if a defunctioning loop stoma used in low anterior resection of the rectum for cancer can be reversed after 14 days instead of 3-12 months which is present clinical practise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
March 10, 2008
CompletedFirst Posted
Study publicly available on registry
March 21, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedMarch 21, 2008
March 1, 2008
1.2 years
March 10, 2008
March 19, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reversal of defunctioning loop stoma on postoperative day 14 following low anterior resection of the rectum for cancer with or without preoperative adjuvant treatment
Preoperatively, postoperative day 7, postoperative day 30 and at 6 months postoperatively
Secondary Outcomes (1)
Postoperative 30 day morbidity. Postoperative ano-rectal function at 1 and 6 months.
Postoperatively at 1 and 6 months.
Study Arms (1)
I
Twenty consecutive patients operated on with low anterior resection of the rectum for cancer with a defunctioning stoma who accept participation.
Interventions
Eligibility Criteria
Twenty patients operated on with low anterior resection of the rectum for cancer and a defunctioning loop stoma.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Surgery, Örebro University Hospital
Örebro, 701 85, Sweden
Biospecimen
Analysis of serum C-Reactive Protein (CRP) and Procalcitonin (PCT).
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Matthiessen, MD, PhD
Department of Surgery, Örebro University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 10, 2008
First Posted
March 21, 2008
Study Start
February 1, 2008
Primary Completion
April 1, 2009
Study Completion
November 1, 2009
Last Updated
March 21, 2008
Record last verified: 2008-03